LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
(NASDAQ: LENZ) Delayed: 4.12 +0.05 (1.23%)
Previous Close $4.07    52 Week High $ 
Open $4.12    52 Week Low $ 
Day High $4.13    P/E N/A 
Day Low $4.00    EPS $ 
Volume 618,081